Expects to deliver three Investigational New Drug (IND) applications in next three years based on next-generation ADC technology - - Two new clinical trials, REFRaME-P1, a registration-enabling trial ...
JMP Securities analyst Andrew Boone raised the firm’s price target on Life360 (LIF) to $55 from $40 and keeps an Outperform rating on the ...
In a report released today, Andrew Boone from JMP Securities reiterated a Buy rating on Life360, Inc. (LIF – Research Report), with a ...
Inovio Pharmaceuticals ( INO -3.64%) Q3 2024 Earnings Call Nov 14, 2024, 4:30 p.m. ET ...
The Los Angeles Rams finally have their starting interior offensive line healthy. But rust was evident when left guard Steve ...
We will hold a question-and-answer session following our prepared remarks. Please note that on today's call, we will be making forward-looking statements, including statements concerning the potential ...
Yaron Kinar; Analyst; Jefferies Financial Group Inc.
Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations ...
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $236.52, along ...
A CHRISTIAN denomination has submitted its plans to convert a former psychiatric unit. The Star reported in October that the Plymouth Brethren Christian Church was seeking to create a place of worship ...